Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "6a153f150f3a1ec7df62ff41", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg", "description": "Glimepiride Voglibose and Metformin Hydrochloride Tablets are a combination anti-diabetic medicine used for the effective management of Type 2 Diabetes Mellitus. This triple-action formulation helps control blood sugar levels through multiple mechanisms, making it highly beneficial for patients who are unable to achieve adequate glucose control with single-drug therapy.\n\nType 2 diabetes is a chronic metabolic disorder that affects the body’s ability to regulate blood sugar properly. Uncontrolled diabetes can lead to severe health complications such as heart disease, kidney damage, nerve disorders, vision problems, and poor circulation. This combination therapy is designed to provide comprehensive glycemic control by improving insulin action, reducing glucose production, and slowing carbohydrate absorption.\n\nDoctors commonly prescribe Glimepiride Voglibose and Metformin Hydrochloride Tablets to support long-term diabetes management and reduce the risk of diabetes-related complications.\n\nWhat are Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine contains three active ingredients that work together to maintain healthy blood sugar levels:\n\nGlimepiride – A sulfonylurea anti-diabetic agent\nVoglibose – An alpha-glucosidase inhibitor\nMetformin Hydrochloride – A biguanide anti-diabetic medicine\n\nEach ingredient targets a different pathway involved in blood sugar regulation, offering a more effective approach for diabetes control.\n\nKey Benefits of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n1. Helps Control Blood Sugar Levels Effectively\n\nThis combination medicine provides comprehensive glucose management throughout the day, especially after meals when blood sugar spikes are common.\n\n2. Improves Insulin Function\n\nGlimepiride stimulates the pancreas to release insulin, helping the body utilize glucose more efficiently.\n\n3. Reduces Excess Glucose Production\n\nMetformin decreases glucose production in the liver and improves insulin sensitivity, making it easier for the body to use available insulin.\n\n4. Controls Post-Meal Sugar Spikes\n\nVoglibose delays carbohydrate digestion and absorption in the intestine, helping prevent sudden increases in blood sugar after meals.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps reduce the risk of complications associated with uncontrolled diabetes, such as kidney disease, nerve damage, and cardiovascular problems.\n\nHow Glimepiride Voglibose and Metformin Hydrochloride Tablets Work\n\nThis triple-drug combination works through complementary mechanisms:\n\nGlimepiride\n\nGlimepiride stimulates beta cells in the pancreas to release insulin. Increased insulin helps lower blood glucose levels by allowing sugar to enter body cells for energy use.\n\nVoglibose\n\nVoglibose inhibits enzymes responsible for breaking down complex carbohydrates into simple sugars. This slows glucose absorption from food and prevents rapid post-meal blood sugar rises.\n\nMetformin Hydrochloride\n\nMetformin reduces glucose production by the liver and enhances insulin sensitivity in muscles and tissues. It also helps decrease intestinal glucose absorption.\n\nTogether, these actions provide balanced and effective blood sugar control throughout the day.\n\nUses of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n\nThis medicine is primarily prescribed for:\n\nType 2 Diabetes Mellitus\nPoorly controlled blood sugar levels\nPostprandial hyperglycemia (high blood sugar after meals)\nDiabetes management in overweight individuals\nCombination therapy when diet and exercise alone are insufficient\n\nIt is usually recommended along with proper diet, exercise, and lifestyle modifications.\n\nDosage and Administration\n\nThe dosage depends on blood sugar levels, patient response, and physician recommendations.\n\nGeneral Usage Guidelines\nUsually taken once or twice daily with meals\nSwallow tablets whole with water\nTake at the same time each day for consistent control\nFollow dietary advice strictly during treatment\n\nDo not skip meals while taking this medicine, as it may increase the risk of low blood sugar.\n\nPatients should regularly monitor blood glucose levels during therapy.\n\nPossible Side Effects\n\nLike any medication, Glimepiride Voglibose and Metformin Hydrochloride Tablets may cause side effects in some individuals.\n\nCommon Side Effects\nNausea\nDiarrhea\nAbdominal discomfort\nGas or bloating\nHeadache\nDizziness\nLow Blood Sugar Symptoms (Hypoglycemia)\n\nGlimepiride may occasionally cause low blood sugar, especially if meals are skipped.\n\nSymptoms include:\n\nSweating\nShaking\nHunger\nWeakness\nFast heartbeat\nConfusion\n\nKeeping a quick sugar source such as glucose tablets or juice is recommended.\n\nRare but Serious Side Effects\nSevere allergic reactions\nLactic acidosis (rare but serious with metformin)\nLiver-related issues\n\nImmediate medical attention should be sought if serious symptoms occur.\n\nPrecautions and Warnings\n\nBefore using this medicine, patients should inform their doctor about any existing medical conditions.\n\nImportant Precautions\nAvoid excessive alcohol consumption\nUse cautiously in kidney or liver disease\nRegular monitoring of kidney function may be required\nElderly patients may need dose adjustments\nInform the doctor before surgery or major illness\nPregnant or breastfeeding women should use only if prescribed\n\nMaintaining proper meal timing and lifestyle habits is important for safe and effective diabetes management.\n\nWho Should Use Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine is suitable for:\n\nAdults with Type 2 Diabetes Mellitus\nPatients with uncontrolled post-meal glucose levels\nIndividuals requiring combination anti-diabetic therapy\nPatients not achieving adequate control with single medicines\nOverweight diabetic individuals needing insulin sensitivity improvement\n\nA healthcare professional will determine the appropriate treatment plan based on medical history and glucose profile.\n\nWhy Choose Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis combination therapy is preferred because it targets multiple aspects of diabetes simultaneously.\n\nAdvantages Include:\nTriple-action blood sugar control\nBetter post-meal glucose management\nImproved insulin utilization\nConvenient combination therapy\nReduces need for multiple separate medicines\nSupports long-term metabolic health\n\nIt offers comprehensive diabetes management in a single tablet formulation.\n\nLifestyle Tips for Better Diabetes Control\n\nAlong with medication, healthy lifestyle changes significantly improve diabetes management.\n\nRecommended Habits\nFollow a balanced diabetic diet\nExercise regularly\nMonitor blood sugar consistently\nMaintain healthy body weight\nAvoid smoking and excessive alcohol\nStay hydrated\nGet regular medical checkups\n\nThese habits help improve treatment effectiveness and reduce complications.\n\nStorage Instructions\nStore in a cool, dry place\nProtect from moisture and direct sunlight\nKeep out of reach of children\nUse only before expiry date\nBuyer Intent Summary\n\nIf you are searching for an effective combination medicine for Type 2 Diabetes management, Glimepiride Voglibose and Metformin Hydrochloride Tablets provide advanced blood sugar control through a triple-action mechanism. This medicine helps reduce fasting and post-meal sugar levels while improving insulin function and metabolic balance.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2428, "imageuri": "https://productimages.withfloats.com/actual/6a153f17d73bfed7b4b4181f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a153f17d73bfed7b4b4181f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-26T06:35:01.356Z", "updatedon": "2026-05-26T06:35:01.356Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg/2428", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose and metformin hydrochloride tablets", "metformin glimepiride voglibose", "glimepiride voglibose metformin", "tab metformin glimepiride voglibose", "glimepiride voglibose and metformin hydrochloride tablets uses", "metformin hydrochloride glimepiride voglibose", "metformin glimepiride voglibose 0.3", "glimepiride voglibose and metformin sr tablets", "glimepiride voglibose and metformin", "metformin glimepiride voglibose uses", "metformin glimepiride voglibose combination", "metformin glimepiride voglibose 0.2", "metformin glimepiride voglibose dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69b3dbf5fe6f1f334a91635f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg (Extended Release) Tablets", "description": "Managing type 2 diabetes mellitus requires a comprehensive approach that focuses on controlling blood glucose levels, improving insulin sensitivity, and supporting overall metabolic health. With the increasing prevalence of diabetes worldwide, combination therapies have become an effective solution to provide better glycemic control through multiple mechanisms.\n\nGLIDAPA TENMET 1000 is a triple-combination antidiabetic medication formulated with Dapagliflozin, Teneligliptin, and Metformin. This advanced formulation is designed to help individuals with type 2 diabetes manage blood sugar levels more effectively when diet, exercise, and single-drug therapy are not sufficient.\n\nThe combination works through different pathways in the body to regulate glucose levels, improve insulin activity, and reduce excess sugar in the bloodstream. As a result, it helps patients maintain better long-term glycemic control and reduce the risk of diabetes-related complications.\n\nComposition and Mechanism of Action\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of medicines known as SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors). These medications work by preventing the kidneys from reabsorbing glucose back into the bloodstream.\n\nInstead, the excess glucose is removed from the body through urine. This process helps lower blood sugar levels independently of insulin and contributes to improved glycemic control.\n\nIn addition, dapagliflozin may also help in modest weight reduction and improved cardiovascular health in some patients.\n\n2. Teneligliptin\n\nTeneligliptin is part of the DPP-4 inhibitor (Dipeptidyl Peptidase-4 inhibitor) class. It works by increasing the levels of incretin hormones in the body.\n\nIncretin hormones play an important role in blood sugar regulation by:\n\nStimulating insulin release from the pancreas when blood glucose levels rise\n\nReducing the production of glucose by the liver\n\nSlowing gastric emptying\n\nThese effects help maintain stable blood sugar levels after meals.\n\n3. Metformin\n\nMetformin is one of the most widely used medications for type 2 diabetes. It works primarily by:\n\nReducing glucose production in the liver\n\nIncreasing insulin sensitivity in body tissues\n\nImproving the body's ability to utilize glucose\n\nMetformin also helps lower fasting blood sugar levels and supports overall metabolic control.\n\nTogether, these three components create a complementary mechanism of action, making GLIDAPA TENMET 1000 an effective therapy for managing diabetes.\n\nUses of GLIDAPA TENMET 1000\n\nThis medication is primarily prescribed for the management of type 2 diabetes mellitus in adults. It is typically recommended when lifestyle changes and single-drug therapy do not provide adequate blood sugar control.\n\n1. Control of Blood Sugar Levels\n\nGLIDAPA TENMET 1000 helps regulate blood glucose levels throughout the day, including both fasting and post-meal sugar levels.\n\n2. Support for Long-Term Diabetes Management\n\nConsistent use of the medication, along with proper diet and exercise, helps maintain stable blood sugar levels over time.\n\n3. Reduction of Insulin Resistance\n\nMetformin improves the body's sensitivity to insulin, allowing glucose to be utilized more effectively by cells.\n\n4. Elimination of Excess Glucose\n\nDapagliflozin helps remove excess sugar through urine, reducing overall blood glucose levels.\n\n5. Improvement of Post-Meal Sugar Levels\n\nTeneligliptin helps regulate the body’s insulin response after meals, preventing sharp spikes in blood sugar.\n\nKey Benefits of GLIDAPA TENMET 1000\n1. Triple Mechanism for Better Control\n\nThe combination of three antidiabetic agents targets multiple pathways involved in glucose regulation, resulting in more effective blood sugar management.\n\n2. Improved Glycemic Stability\n\nThe medication helps control both fasting and postprandial (after meal) blood glucose levels.\n\n3. Supports Weight Management\n\nUnlike some diabetes medications that may cause weight gain, dapagliflozin may contribute to modest weight reduction in certain individuals.\n\n4. Cardiovascular Support\n\nSGLT2 inhibitors like dapagliflozin have been associated with potential heart health benefits in certain patients with diabetes.\n\n5. Convenient Combination Therapy\n\nInstead of taking multiple medications separately, this single tablet combines three active ingredients, making diabetes management more convenient.\n\n6. Reduced Risk of Diabetes Complications\n\nMaintaining controlled blood sugar levels helps reduce the risk of long-term complications such as nerve damage, kidney disease, and eye problems.\n\nPossible Side Effects\n\nWhile GLIDAPA TENMET 1000 is generally well tolerated, some individuals may experience side effects. These effects are usually mild and temporary but should be monitored.\n\nCommon Side Effects\n\nNausea\n\nStomach upset\n\nDiarrhea\n\nIncreased urination\n\nHeadache\n\nModerate Side Effects\n\nDizziness\n\nUrinary tract infections\n\nLow blood sugar (especially when used with other antidiabetic medications)\n\nFatigue\n\nRare Side Effects\n\nDehydration\n\nSevere gastrointestinal discomfort\n\nAllergic reactions such as rash or itching\n\nLactic acidosis (rare but serious complication associated with metformin)\n\nIf any severe or persistent symptoms occur, medical attention should be sought immediately.\n\nPrecautions\n\nCertain precautions should be considered before using this medication:\n\nThe medicine should only be taken under medical supervision.\n\nPatients with kidney disease or liver disorders should consult their doctor before starting treatment.\n\nAdequate hydration is important while taking SGLT2 inhibitors like dapagliflozin.\n\nAlcohol consumption should be limited, as it may increase the risk of certain side effects.\n\nBlood glucose levels should be monitored regularly to ensure proper control.\n\nPregnant or breastfeeding women should consult a healthcare professional before using this medication.\n\nLifestyle Recommendations for Better Results\n\nFor optimal results, medication should be combined with healthy lifestyle habits, including:\n\nMaintaining a balanced diet low in refined sugars\n\nEngaging in regular physical activity\n\nMonitoring blood glucose levels regularly\n\nMaintaining a healthy body weight\n\nFollowing the doctor’s prescribed treatment plan\n\nLifestyle modifications significantly enhance the effectiveness of diabetes medications.\n\nConclusion\n\nType 2 diabetes is a chronic condition that requires consistent management to prevent long-term complications and maintain overall health. Combination therapies have become an important part of modern diabetes treatment because they target multiple aspects of blood sugar regulation.", "price": 223.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2326, "imageuri": "https://productimages.withfloats.com/actual/69b3dc555c5e1bebb0f137b9.png", "tileimageuri": "https://productimages.withfloats.com/tile/69b3dc555c5e1bebb0f137b9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-13T09:42:13.961Z", "updatedon": "2026-03-14T10:54:48.766Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-mg-teneligliptin-20-mg-metformin-hydrochloride-1000-mg-extended-release-tablets/2326", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENMET 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69affd814f6df2ce02d820ab", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metformin Hydrochloride Prolonged Release", "description": "Metformin Hydrochloride Prolonged Release Tablets for Effective Blood Sugar Control\n\nManaging diabetes requires a combination of proper medication, a balanced lifestyle, and regular monitoring of blood glucose levels. For individuals living with type 2 diabetes, maintaining stable blood sugar levels is essential to prevent complications and ensure overall health. SEIZMET 500, formulated with Metformin Hydrochloride Prolonged Release, is a trusted oral medication designed to help control blood sugar levels in adults diagnosed with type 2 diabetes mellitus.\n\nSEIZMET 500 works by improving the body's response to insulin and reducing the amount of glucose produced by the liver. Its prolonged-release formulation allows the medicine to work gradually throughout the day, providing consistent blood sugar control while reducing gastrointestinal discomfort that may occur with immediate-release forms of metformin.\n\nThis medication is widely recommended by healthcare professionals as a first-line treatment for type 2 diabetes, especially for patients who need effective glycemic control along with long-term metabolic support.\n\nProduct Description\n\nSEIZMET 500 is an oral antidiabetic medication containing Metformin Hydrochloride in a prolonged-release formulation. Metformin belongs to a class of medicines known as biguanides, which are commonly prescribed to manage type 2 diabetes.\n\nUnlike many diabetes medications that stimulate the pancreas to produce more insulin, Metformin works through multiple mechanisms that improve the body’s natural ability to regulate blood sugar. It reduces excess glucose production in the liver, increases insulin sensitivity, and enhances the uptake of glucose by muscles and tissues.\n\nThe prolonged-release (PR) technology used in SEIZMET 500 ensures that the medicine is released slowly into the bloodstream over time. This gradual release helps maintain stable blood sugar levels throughout the day and minimizes sudden spikes or fluctuations in glucose levels.\n\nSEIZMET 500 is typically prescribed along with dietary modifications, exercise, and regular monitoring of blood glucose levels to achieve optimal diabetes management.\n\nComposition\n\nEach tablet of SEIZMET 500 contains:\n\nMetformin Hydrochloride Prolonged Release – 500 mg\n\nThis controlled-release formulation provides sustained therapeutic action and improved patient tolerance.\n\nUses of SEIZMET 500\n\nSEIZMET 500 is primarily used for the treatment and management of type 2 diabetes mellitus. It helps control blood sugar levels in individuals whose glucose levels cannot be adequately managed through lifestyle changes alone.\n\n1. Treatment of Type 2 Diabetes\n\nThe primary use of SEIZMET 500 is to manage elevated blood sugar levels in adults diagnosed with type 2 diabetes.\n\n2. Improving Glycemic Control\n\nThe medication helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic stability.\n\n3. Supporting Insulin Sensitivity\n\nMetformin enhances the body's sensitivity to insulin, allowing cells to use glucose more effectively for energy.\n\n4. Prevention of Diabetes Complications\n\nBy maintaining proper blood sugar levels, SEIZMET 500 may help reduce the risk of complications such as nerve damage, kidney disease, vision problems, and cardiovascular conditions.\n\n5. Management of Insulin Resistance\n\nMetformin is known for its ability to reduce insulin resistance, which is a major factor contributing to type 2 diabetes.\n\nHow SEIZMET 500 Works\n\nSEIZMET 500 works through several mechanisms that help control blood glucose levels:\n\nReduces Liver Glucose Production\nThe liver produces glucose even when the body does not need it. Metformin helps decrease this excessive glucose production.\n\nImproves Insulin Sensitivity\nThe medication helps body tissues respond better to insulin, allowing glucose to enter cells more efficiently.\n\nEnhances Glucose Utilization\nMuscles and other tissues use glucose more effectively for energy.\n\nDecreases Intestinal Glucose Absorption\nMetformin slows down the absorption of glucose from the digestive tract after meals.\n\nThe prolonged-release technology ensures that these actions occur steadily throughout the day.\n\nKey Benefits of SEIZMET 500\n1. Effective Blood Sugar Control\n\nSEIZMET 500 helps maintain healthy blood glucose levels, reducing the risk of hyperglycemia.\n\n2. Sustained Drug Release\n\nThe prolonged-release formulation provides gradual drug release, ensuring consistent therapeutic effects.\n\n3. Lower Risk of Hypoglycemia\n\nUnlike some diabetes medications, metformin rarely causes dangerously low blood sugar when used alone.\n\n4. Improved Insulin Sensitivity\n\nSEIZMET 500 improves the body's response to insulin, allowing glucose to be used more efficiently.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps maintain stable glucose levels and supports overall metabolic health.\n\n6. Reduced Gastrointestinal Side Effects\n\nThe prolonged-release formulation helps minimize stomach-related side effects commonly associated with immediate-release metformin.\n\n7. Weight-Neutral or Weight-Friendly\n\nMetformin may help prevent weight gain and in some cases may support mild weight reduction, which can benefit people with type 2 diabetes.\n\nHow to Use SEIZMET 500\n\nTo achieve the best results, SEIZMET 500 should be taken according to the instructions provided by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with meals to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush, chew, or break the prolonged-release tablet.\n\nFollow the dosage and schedule prescribed by your doctor.\n\nMaintain a healthy diet and regular exercise routine.\n\nConsistency in taking the medication is essential for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, SEIZMET 500 may cause side effects in some individuals. Most side effects are mild and temporary, especially during the early stages of treatment.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nStomach upset\n\nLoss of appetite\n\nMild abdominal discomfort\n\nThese symptoms often improve as the body adjusts to the medication.\n\nLess Common Side Effects\n\nMetallic taste in the mouth\n\nVitamin B12 deficiency with long-term use\n\nMild weakness or fatigue\n\nRare but Serious Side Effects\n\nLactic acidosis, a rare but serious condition associated with metformin use in patients with severe kidney problems\n\nSevere allergic reactions\n\nIf symptoms such as unusual muscle pain, difficulty breathing, severe weakness, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking SEIZMET 500, inform your healthcare provider if you have:\n\nKidney disease\n\nLiver disorders\n\nHeart conditions\n\nSevere infections\n\nA history of alcohol abuse\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nRegularly monitor blood sugar levels.\n\nAttend routine medical checkups.\n\nInform your doctor about any other medications you are taking.\n\nLifestyle Recommendations for Better Results\n\nMedication alone may not be enough to manage diabetes effectively. Individuals taking SEIZMET 500 should also focus on healthy lifestyle habits such as:\n\nMaintaining a balanced and nutritious diet\n\nEngaging in regular physical activity\n\nMonitoring blood sugar levels regularly\n\nMaintaining a healthy body weight\n\nFollowing medical advice and attending regular health checkups\n\nThese steps help maximize the benefits of the medication and support overall health.\n\nConclusion\n\nType 2 diabetes is a long-term condition that requires consistent management to maintain healthy blood sugar levels and prevent complications. SEIZMET 500, containing Metformin Hydrochloride Prolonged Release, offers an effective and reliable treatment option for individuals seeking better glucose control.", "price": 31.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2324, "imageuri": "https://productimages.withfloats.com/actual/69affdab1344531582e8f29c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69affdab1344531582e8f29c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T11:16:17.511Z", "updatedon": "2026-03-14T12:11:16.322Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-prolonged-release/2324", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET 500", "category": "DIABETIC RANGE", "tags": [ "metformin hydrochloride prolonged release tablets", "metformin hydrochloride slow release tablets", "prolonged release metformin 500 mg tablets", "metformin hcl pr tablets for diabetes", "metformin hydrochloride controlled release tablet", "metformin hydrochloride 1000 mg prolonged release", "diabetes management tablets metformin prolonged release", "medicine for type 2 diabetes metformin pr tablets", "slow release metformin tablets for high blood sugar", "extended release metformin tablets for blood sugar management", "metformin hydrochloride extended release for insulin resistance", "buy metformin hydrochloride prolonged release tablets", "metformin pr tablets price", "SEIZMET 500 metformin hydrochloride prolonged release price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69afcdd7726d81b4833817a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin linagliptin", "description": "Advanced Combination Therapy with Metformin and Linagliptin for Effective Blood Sugar Control\n\nManaging type 2 diabetes requires consistent care, the right medication, and lifestyle management to maintain healthy blood glucose levels. Modern diabetes treatment often uses combination therapies that work through different mechanisms to provide better control and long-term health benefits. LINALIGOLD M 2.5/1000 is a scientifically formulated anti-diabetic medication that combines Metformin (1000 mg) and Linagliptin (2.5 mg) to help manage blood sugar levels effectively in adults with type 2 diabetes mellitus.\n\nThis dual-action tablet is designed to improve glycemic control when diet and exercise alone are not sufficient. By targeting different pathways involved in glucose regulation, LINALIGOLD M 2.5/1000 helps maintain stable blood sugar levels, supports metabolic health, and reduces the risk of diabetes-related complications.\n\nProduct Description\n\nLINALIGOLD M 2.5/1000 is a combination anti-diabetic medication that brings together two well-established drugs used in diabetes management: Metformin, a biguanide that reduces glucose production in the liver and improves insulin sensitivity, and Linagliptin, a DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar levels.\n\nThis powerful combination works synergistically to control blood glucose levels throughout the day. While Metformin helps decrease the amount of sugar released into the bloodstream from the liver, Linagliptin increases the activity of incretin hormones, which stimulate insulin release when blood sugar levels are high.\n\nLINALIGOLD M 2.5/1000 is commonly prescribed for patients with type 2 diabetes mellitus who require improved glycemic control and who may not achieve adequate results with a single medication.\n\nKey Ingredients and Their Role\nMetformin (1000 mg)\n\nMetformin is one of the most widely used medications for the treatment of type 2 diabetes. It works primarily by:\n\nReducing glucose production in the liver\n\nImproving the body's sensitivity to insulin\n\nIncreasing glucose uptake by muscle cells\n\nReducing absorption of glucose from the intestines\n\nThese actions help lower fasting and post-meal blood sugar levels while supporting overall metabolic balance.\n\nLinagliptin (2.5 mg)\n\nLinagliptin belongs to a class of medications known as DPP-4 inhibitors. It works by increasing levels of incretin hormones in the body, which help regulate blood glucose levels. Its actions include:\n\nStimulating insulin release after meals\n\nReducing excessive glucose production by the liver\n\nLowering postprandial (after meal) blood sugar levels\n\nSupporting natural glucose regulation without causing sudden drops in blood sugar\n\nTogether, these two ingredients provide a comprehensive approach to diabetes management.\n\nUses of LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 is primarily used for the treatment and management of type 2 diabetes mellitus in adults. It helps maintain proper blood sugar levels and supports long-term metabolic health.\n\n1. Management of Type 2 Diabetes\n\nThis medication is prescribed to help control blood sugar levels in individuals diagnosed with type 2 diabetes when lifestyle modifications alone are not enough.\n\n2. Improvement of Glycemic Control\n\nThe dual mechanism of action helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic control.\n\n3. Prevention of Diabetes Complications\n\nProper management of blood sugar levels helps reduce the risk of diabetes-related complications such as nerve damage, kidney problems, eye disorders, and cardiovascular disease.\n\n4. Support for Insulin Sensitivity\n\nMetformin helps improve the body's response to insulin, making it easier for cells to utilize glucose efficiently.\n\nKey Benefits of LINALIGOLD M 2.5/1000\n1. Dual Mechanism for Better Blood Sugar Control\n\nThe combination of Metformin and Linagliptin provides a two-way approach to controlling blood glucose levels by addressing multiple pathways involved in glucose metabolism.\n\n2. Helps Maintain Stable Blood Sugar Levels\n\nLINALIGOLD M 2.5/1000 helps regulate blood sugar throughout the day, including after meals when glucose levels tend to spike.\n\n3. Supports Natural Insulin Activity\n\nLinagliptin enhances the body's natural insulin response without forcing the pancreas to overwork.\n\n4. Reduces Risk of Blood Sugar Spikes\n\nBy controlling glucose production in the liver and improving insulin efficiency, the medication helps prevent sudden increases in blood sugar.\n\n5. Improves Overall Metabolic Health\n\nRegular use, along with proper diet and exercise, supports better metabolic balance and energy utilization in the body.\n\n6. Convenient Combination Therapy\n\nInstead of taking multiple medications separately, this fixed-dose combination simplifies diabetes management and improves treatment adherence.\n\n7. Lower Risk of Hypoglycemia\n\nCompared with some other diabetes medications, Linagliptin generally carries a lower risk of causing dangerously low blood sugar levels when used appropriately.\n\nHow to Use LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 should be taken exactly as prescribed by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with food to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush or chew unless advised.\n\nFollow the dosage and schedule recommended by your doctor.\n\nMaintain a healthy diet and regular physical activity for optimal results.\n\nConsistent use is important for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, LINALIGOLD M 2.5/1000 may cause side effects in some individuals, although not everyone experiences them. Most side effects are mild and temporary as the body adjusts to the medication.\n\nCommon side effects may include:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nLoss of appetite\n\nMild headache\n\nFatigue\n\nLess common but possible side effects include:\n\nUpper respiratory symptoms such as cough or sore throat\n\nMild skin reactions\n\nVitamin B12 deficiency with long-term use of metformin\n\nRare but serious side effects may include:\n\nSevere allergic reactions\n\nLactic acidosis (a rare but serious condition associated with metformin)\n\nPancreatitis in rare cases related to DPP-4 inhibitors\n\nIf symptoms such as severe abdominal pain, unusual weakness, breathing difficulty, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking LINALIGOLD M 2.5/1000, it is important to consult a healthcare professional, especially if you have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of pancreatitis\n\nSevere infections or dehydration\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about all medications you are currently taking.\n\nRegular blood sugar monitoring is recommended.\n\nLifestyle Recommendations for Better Results\n\nMedication works best when combined with healthy lifestyle practices. Patients using LINALIGOLD M 2.5/1000 are encouraged to:\n\nFollow a balanced diabetic-friendly diet\n\nEngage in regular physical activity\n\nMaintain a healthy body weight\n\nMonitor blood glucose levels regularly\n\nAttend routine medical checkups\n\nThese habits can significantly improve diabetes management and overall health.\n\nConclusion\nType 2 diabetes is a chronic condition that requires consistent and effective management to prevent long-term health complications. LINALIGOLD M 2.5/1000 offers a modern combination therapy that integrates the glucose-lowering effects of metformin with the incretin-enhancing action of Linagliptin, providing a comprehensive approach to blood sugar control.", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2323, "imageuri": "https://productimages.withfloats.com/actual/69afcdd9ea5ba715c39c99dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69afcdd9ea5ba715c39c99dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T07:52:55.329Z", "updatedon": "2026-03-13T09:13:04.519Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-linagliptin/2323", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGOLD M 2.5/1000", "category": "DIABETIC RANGE", "tags": [ "metformin and linagliptin tablets for diabetes", "metformin linagliptin oral diabetes medication", "linagliptin 2.5 mg metformin 1000 mg tablet", "medicine for type 2 diabetes metformin linagliptin", "best medicine combination for type 2 diabetes", "blood sugar control medicine with metformin", "tablet for fasting and post meal sugar control", "how metformin linagliptin works for diabetes", "metformin linagliptin dosage for type 2 diabetes", "metformin linagliptin tablet price", "linagliptin metformin tablets wholesale price", "LINALIGOLD M metformin linagliptin tablet price", "LINALIGOLD M tablet for type 2 diabetes", "metformin linagliptin tablets india", "linagliptin metformin tablet manufacturer india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69a9837a9c219e2cff873568", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin glimepiride metformin tablet", "description": "Composition: Dapagliflozin 10 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg (Extended Release)\n\nManaging type 2 diabetes requires a balanced approach that includes proper medication, healthy lifestyle choices, and regular monitoring of blood sugar levels. Modern diabetes management often involves combination therapies that target blood glucose control through multiple mechanisms. One such effective combination medicine is GLIDAPAFLOZIN TRIO 2.\n\nThis medication contains three well-known antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation. Together, these medicines work in different ways to help control blood sugar levels effectively in adults with type 2 diabetes.\n\nThis article provides a comprehensive overview of the product, its uses, benefits, possible side effects, and important information patients should know before using it.\n\nProduct Overview\n\nGLIDAPAFLOZIN TRIO 2 is a triple-combination oral antidiabetic tablet designed to help manage blood glucose levels in patients diagnosed with Type 2 Diabetes.\n\nEach tablet contains:\n\nDapagliflozin 10 mg\n\nGlimepiride 2 mg\n\nMetformin Hydrochloride 500 mg (Extended Release)\n\nThese ingredients work together to reduce high blood sugar levels through complementary mechanisms, helping patients achieve better glycemic control.\n\nCombination therapy like this is commonly recommended when a single medication alone is not sufficient to manage blood glucose levels.\n\nHow the Medicine Works\n\nThe three active ingredients in GLIDAPAFLOZIN TRIO 2 work through different pathways in the body.\n\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of drugs known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the body through urine. This reduces blood sugar levels and may also provide additional cardiovascular and kidney benefits in some patients.\n\n2. Glimepiride\n\nGlimepiride stimulates the pancreas to release more insulin. Insulin is the hormone responsible for moving glucose from the bloodstream into cells where it can be used as energy.\n\n3. Metformin Hydrochloride (Extended Release)\n\nMetformin Hydrochloride helps lower blood sugar by reducing glucose production in the liver and improving insulin sensitivity in the body. The extended-release formulation ensures a steady release of the medicine over time, improving tolerance and effectiveness.\n\nTogether, these three medicines provide a comprehensive approach to blood sugar management.\n\nUses of GLIDAPAFLOZIN TRIO 2\n\nGLIDAPAFLOZIN TRIO 2 is primarily prescribed for the management of Type 2 Diabetes in adults.\n\nMain Uses\n\nBlood Sugar Control\nThe medication helps reduce high blood glucose levels in patients whose diabetes is not adequately controlled with diet, exercise, or single-drug therapy.\n\nImproving Insulin Function\nIt improves the body’s response to insulin and helps regulate glucose metabolism.\n\nPreventing Diabetes Complications\nProper blood sugar control reduces the risk of long-term complications such as nerve damage, kidney disease, vision problems, and cardiovascular issues.\n\nSupporting Weight and Metabolic Health\nThe presence of dapagliflozin may help some patients experience mild weight reduction and improved metabolic balance.\n\nKey Benefits\n\nThe combination of three effective antidiabetic agents offers several important benefits.\n\n1. Triple Mechanism Action\n\nThe medicine works through three complementary mechanisms, targeting multiple causes of high blood sugar.\n\n2. Better Glycemic Control\n\nPatients often achieve improved HbA1c levels compared to single-drug therapy.\n\n3. Reduced Risk of Long-Term Complications\n\nMaintaining controlled blood sugar levels helps prevent complications associated with diabetes.\n\n4. Convenient Single Tablet Therapy\n\nInstead of taking multiple medicines separately, patients can manage their treatment with a single tablet, improving medication adherence.\n\n5. Extended Release Technology\n\nThe extended-release formulation of Metformin Hydrochloride ensures gradual drug release, reducing stomach discomfort and improving patient tolerance.\n\n6. Improved Energy and Daily Functioning\n\nProper blood sugar control helps patients feel more energetic and maintain better overall health.\n\nPossible Side Effects\n\nLike all medications, GLIDAPAFLOZIN TRIO 2 may cause some side effects. However, not everyone experiences them.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea or vomiting\n\nDiarrhea\n\nHeadache\n\nIncreased urination\n\nLow blood sugar (hypoglycemia), especially when meals are skipped\n\nLess Common Side Effects\n\nUrinary tract infections\n\nDizziness or weakness\n\nMild dehydration\n\nRare but Serious Effects\n\nSevere hypoglycemia\n\nLactic acidosis (very rare but serious condition linked with metformin)\n\nAllergic reactions\n\nPatients should immediately consult a healthcare professional if they experience unusual symptoms such as severe weakness, difficulty breathing, or persistent stomach pain.\n\nPrecautions and Safety Advice\n\nBefore starting GLIDAPAFLOZIN TRIO 2, patients should inform their doctor if they have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of severe dehydration\n\nAny known drug allergies\n\nPatients should also avoid skipping meals and maintain proper hydration to reduce the risk of low blood sugar.\n\nRegular monitoring of blood glucose levels is important while using this medication.\n\nLifestyle Tips for Better Results\n\nMedication alone cannot control diabetes. Patients should combine treatment with healthy habits.\n\nRecommended lifestyle practices include:\n\nMaintaining a balanced diabetic diet\n\nExercising regularly\n\nMonitoring blood sugar levels\n\nAvoiding excessive sugar and processed foods\n\nManaging stress levels\n\nGetting sufficient sleep\n\nThese lifestyle changes enhance the effectiveness of diabetes medications.\n\nConclusion\nManaging diabetes requires a consistent and comprehensive approach. Combination medicines like GLIDAPAFLOZIN TRIO 2 provide an effective solution for patients who need stronger glucose control than single-drug therapy can offer.", "price": 184.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2317, "imageuri": "https://productimages.withfloats.com/actual/69a9837cad119d5b47141190.png", "tileimageuri": "https://productimages.withfloats.com/tile/69a9837cad119d5b47141190.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-05T13:22:02.718Z", "updatedon": "2026-03-13T11:05:08.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-glimepiride-metformin-tablet/2317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN TRIO 2", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin glimepiride metformin tablet uses and dosage", "dapagliflozin glimepiride metformin combination tablet benefits", "dapagliflozin glimepiride metformin tablet side effects in adults", "dapagliflozin glimepiride metformin tablet how it works", "dapagliflozin glimepiride metformin tablet benefits for sugar control", "buy dapagliflozin glimepiride metformin tablet online", "dapagliflozin glimepiride metformin tablet price in india", "dapagliflozin glimepiride metformin tablet for uncontrolled diabetes", "dapagliflozin glimepiride metformin tablet triple therapy medicine", "dapagliflozin glimepiride metformin tablet dosage guide for adults" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696e129c1d5e7fc4677fb603", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin hydrochloride 850 mg and Glimepiride 2 mg", "description": "Diabetes mellitus is one of the most common chronic lifestyle disorders worldwide, affecting millions of people and requiring long-term management. Type 2 diabetes, in particular, occurs when the body either does not produce enough insulin or cannot use insulin effectively. To manage this condition successfully, combination therapy is often recommended when a single medicine is not sufficient to control blood sugar levels.\n\nMetformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets, marketed under the brand name SEIZMET G2 850, is a well-established and effective oral anti-diabetic combination. It is designed to control blood glucose levels through dual action, addressing both insulin resistance and inadequate insulin secretion.\n\nWhat is SEIZMET G2 850?\n\nSEIZMET G2 850 is a combination of two powerful anti-diabetic agents:\n\nMetformin Hydrochloride 850 mg\n\nGlimepiride 2 mg\n\nThis combination is widely prescribed for adults with Type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate glycemic control. By combining two complementary mechanisms, SEIZMET G2 850 helps achieve better and more stable blood sugar management.\n\nUses of Metformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets\n\nThe primary use of SEIZMET G2 850 is the management of Type 2 diabetes mellitus. It is prescribed to:\n\nLower elevated blood glucose levels\n\nImprove insulin sensitivity\n\nEnhance insulin secretion from the pancreas\n\nPrevent diabetes-related complications\n\nThis medicine is especially beneficial for patients who experience persistent high blood sugar despite lifestyle modifications or single-drug therapy.\n\nHow SEIZMET G2 850 Works\n\nSEIZMET G2 850 works through a dual-action mechanism, ensuring effective blood sugar control throughout the day.\n\nRole of Metformin Hydrochloride\n\nMetformin primarily works by:\n\nReducing glucose production in the liver\n\nImproving insulin sensitivity in muscle and fat tissues\n\nDecreasing glucose absorption from the intestine\n\nIt does not cause excessive insulin release, which makes it less likely to cause hypoglycemia when used alone.\n\nRole of Glimepiride\n\nGlimepiride belongs to the sulfonylurea class and works by:\n\nStimulating the pancreas to release insulin\n\nImproving the body’s response to insulin\n\nLowering post-meal blood sugar spikes\n\nTogether, these actions make SEIZMET G2 850 a comprehensive and balanced treatment option for diabetes control.\n\nKey Benefits of SEIZMET G2 850\n\nSEIZMET G2 850 offers several important benefits for patients with Type 2 diabetes:\n\n1. Effective Blood Sugar Control\n\nThe combination ensures both fasting and post-prandial glucose levels remain within the target range.\n\n2. Dual Mechanism for Better Results\n\nBy addressing insulin resistance and insulin deficiency simultaneously, it provides superior glycemic control compared to single-drug therapy.\n\n3. Reduces Risk of Diabetes Complications\n\nProper blood sugar control helps reduce the risk of complications such as nerve damage, kidney disease, eye problems, and cardiovascular disorders.\n\n4. Improves Quality of Life\n\nStable glucose levels lead to better energy levels, improved well-being, and fewer diabetes-related symptoms.\n\n5. Convenient Combination Therapy\n\nCombining two medicines in one tablet improves patient compliance and simplifies daily medication routines.\n\nDosage and Administration\n\nThe dosage of SEIZMET G2 850 should be determined by a healthcare professional based on:\n\nBlood glucose levels\n\nAge and body weight\n\nKidney and liver function\n\nIndividual response to treatment\n\nThe tablet is usually taken once or twice daily with meals to reduce the risk of stomach upset and hypoglycemia. Patients should take the medicine at the same time each day for best results.\n\nIt is important to follow dietary advice, regular exercise, and blood glucose monitoring alongside medication.\n\nPossible Side Effects of SEIZMET G2 850\n\nLike all medicines, Metformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets may cause side effects in some individuals.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nAbdominal discomfort\n\nHeadache\n\nDizziness\n\nThese side effects are usually mild and temporary and often improve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nHypoglycemia (low blood sugar), especially if meals are skipped\n\nLactic acidosis (rare but serious, associated with metformin)\n\nAllergic reactions such as skin rash or itching\n\nLiver function abnormalities\n\nPatients should seek medical attention if they experience symptoms such as excessive sweating, confusion, extreme weakness, breathing difficulty, or persistent stomach pain.\n\nPrecautions and Warnings\n\nSEIZMET G2 850 should be used only under medical supervision.\n\nPatients with kidney, liver, or heart disease should inform their doctor before use.\n\nAlcohol consumption should be avoided, as it may increase the risk of side effects.\n\nPregnant and breastfeeding women should consult their doctor before taking this medicine.\n\nRegular monitoring of blood sugar levels is essential to avoid hypoglycemia or uncontrolled diabetes.\n\nWho Should Use SEIZMET G2 850?\n\nSEIZMET G2 850 is suitable for:\n\nAdults diagnosed with Type 2 diabetes\n\nPatients inadequately controlled on metformin or glimepiride alone\n\nIndividuals requiring combination therapy for better glycemic control\n\nIt is not recommended for Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nMetformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets (SEIZMET G2 850) is a trusted and effective combination therapy for the management of Type 2 diabetes mellitus. By combining the benefits of metformin and glimepiride, it offers comprehensive blood sugar control, reduces the risk of long-term complications, and improves overall quality of life.", "price": 102.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2280, "imageuri": "https://productimages.withfloats.com/actual/696e12d9cb45a8390116f1bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/696e12d9cb45a8390116f1bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T11:16:44.772Z", "updatedon": "2026-03-13T11:01:31.908Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-850-mg-and-glimepiride-2-mg/2280", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G2 850", "category": "DIABETIC RANGE", "tags": [ "metformin hydrochloride 850 mg and glimepiride 2 mg tablets", "metformin 850 mg glimepiride 2 mg combination tablet", "glimepiride 2 mg with metformin 850 mg tablets", "metformin glimepiride fixed dose combination tablets", "metformin 850 mg glimepiride 2 mg dosage", "metformin glimepiride tablets for type 2 diabetes", "metformin and glimepiride tablets uses in diabetes", "metformin 850 mg glimepiride 2 mg for blood sugar control", "metformin glimepiride tablets mechanism of action", "metformin glimepiride tablets benefits", "metformin 850 mg glimepiride 2 mg side effects", "metformin glimepiride tablets precautions", "glimepiride metformin tablets safety in diabetes", "metformin glimepiride tablets contraindications", "metformin glimepiride tablets warnings", "metformin glimepiride tablets dosage guidelines", "how to take metformin 850 mg and glimepiride 2 mg tablets", "metformin glimepiride tablets before or after food", "metformin glimepiride tablets daily dose", "metformin glimepiride tablets price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6911af10f122e2a45d230b07", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 2 mg", "description": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg is a triple-combination oral anti-diabetic medication formulated to achieve optimal blood sugar control in adults with Type 2 Diabetes Mellitus (T2DM). This unique blend brings together three complementary agents — Sitagliptin (a DPP-4 inhibitor), Metformin (a biguanide), and Glimepiride (a sulfonylurea) — that work through distinct mechanisms to enhance glucose regulation, improve insulin sensitivity, and support overall metabolic balance.\n\nThis advanced combination therapy is prescribed when monotherapy or dual therapy fails to achieve adequate glycemic control. It helps reduce both fasting plasma glucose (FPG) and postprandial glucose (PPG) levels, promoting stable long-term glycemic management.\n\nUses of Sitagliptin + Metformin + Glimepiride\n\nThis fixed-dose combination is primarily indicated for the management of Type 2 Diabetes Mellitus in adults. It is especially beneficial for patients whose blood sugar levels remain uncontrolled despite treatment with Metformin and Glimepiride or Metformin and Sitagliptin alone.\n\nIts main objectives include:\n\nControlling elevated blood glucose levels in adults with Type 2 diabetes\n\nReducing the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular diseases\n\nSupporting better insulin utilization by the body\n\nComplementing diet, exercise, and lifestyle modification to maintain optimal glycemic balance\n\nMechanism of Action\n\nEach component of this combination plays a vital role in maintaining blood sugar control:\n\nSitagliptin (50 mg) – A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones. These hormones stimulate insulin release and suppress glucagon production when blood glucose levels rise, thereby improving post-meal glucose control.\n\nMetformin Hydrochloride (1000 mg) – A biguanide that lowers glucose production in the liver and increases the body’s sensitivity to insulin. It also decreases intestinal glucose absorption, making it an essential first-line therapy in diabetes management.\n\nGlimepiride (2 mg) – A sulfonylurea that stimulates pancreatic beta cells to release more insulin, especially when blood glucose levels are high. It works synergistically with Metformin and Sitagliptin for more effective glycemic control.\n\nKey Benefits\n\nTriple Mechanism for Superior Control:\nBy combining three potent agents, the medication addresses multiple pathways of glucose regulation—insulin secretion, insulin sensitivity, and hepatic glucose output—resulting in comprehensive and consistent control of blood sugar levels.\n\nEffective Glycemic Stability:\nThe combination helps maintain target HbA1c levels and reduces both fasting and post-meal glucose spikes without significant weight gain when used with proper diet and exercise.\n\nReduced Risk of Diabetic Complications:\nLong-term blood sugar control minimizes the risk of complications such as kidney disease, vision problems, nerve damage, and heart conditions associated with uncontrolled diabetes.\n\nConvenient Fixed-Dose Formulation:\nCombining three medications into a single tablet simplifies dosing schedules, improves patient adherence, and reduces pill burden, which is crucial for long-term treatment success.\n\nImproved Insulin Efficiency:\nEnhances the body's natural insulin response and glucose metabolism, allowing for smoother daily energy levels and reduced fatigue associated with hyperglycemia.\n\nPossible Side Effects\n\nWhile this combination is generally well tolerated, some patients may experience side effects, especially at the beginning of therapy. Common and rare side effects include:\n\nHypoglycemia (low blood sugar): More likely when meals are skipped or during excessive physical exertion. Symptoms include sweating, dizziness, and rapid heartbeat.\n\nGastrointestinal disturbances: Such as nausea, vomiting, diarrhea, abdominal discomfort, or loss of appetite (mostly due to Metformin).\n\nHeadache or Weakness: Usually mild and transient.\n\nAllergic reactions: Rarely, rash or itching may occur.\n\nLactic Acidosis (rare but serious): A potential complication of Metformin, particularly in patients with kidney impairment or excessive alcohol consumption.\n\nWeight gain: Mild weight gain may occur due to Glimepiride’s insulin-enhancing effect.\n\nPrecautions:\n\nRegular monitoring of blood sugar levels and kidney function is essential.\n\nAvoid alcohol and consult a doctor before using this medicine if you have liver or kidney disease.\n\nThe medication should not be used in patients with Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nThe combination of Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg represents a powerful and balanced therapy for adults with Type 2 Diabetes Mellitus, especially those requiring triple-drug intervention to achieve desired glycemic control. Its multi-targeted approach ensures effective management of both fasting and postprandial glucose levels, thereby improving long-term metabolic health and reducing the risk of complications.", "price": 295.0, "discountamount": 89.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2197, "imageuri": "https://productimages.withfloats.com/actual/6911af137e4c90e1dc453884.png", "tileimageuri": "https://productimages.withfloats.com/tile/6911af137e4c90e1dc453884.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-10T09:23:28.795Z", "updatedon": "2026-03-13T10:41:32.995Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-2-mg/2197", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+2 ", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg", "anti-diabetic medication", "blood sugar control", "Type 2 Diabetes Mellitus" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad74702e53c888beeab308d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets", "description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n", "price": 210.0, "discountamount": 147.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2505, "imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:48:34.116Z", "updatedon": "2026-10-20T10:48:34.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 10", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad7442bf24c5a4bbccf4b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets", "description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.", "price": 230.0, "discountamount": 69.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2504, "imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:36:27.325Z", "updatedon": "2026-10-20T10:36:27.325Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 25", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
treatment for diabetic nerve damage?

Still searching for
treatment for diabetic nerve damage?

Chat with us